{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:10:08Z","timestamp":1758748208090,"version":"3.44.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigacion y Desarrollo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010477","name":"Intuitive Surgical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019714","name":"Foundation Medicine","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/100019714","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancessurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Surgery"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.yasu.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T11:03:01Z","timestamp":1686826981000},"page":"141-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is Nonoperative Management of Rectal Cancer Feasible?"],"prefix":"10.1016","volume":"57","author":[{"given":"Felipe F.","family":"Quezada-Diaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse Joshua","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yasu.2023.05.001_bib1","unstructured":"National Comprehensive Cancer Network. NCCN guidelines: rectal cancer. Available at: www.nccn.org\/professionals\/physician_gls\/pdf\/rectal.pdf. Accessed January 11, 2019."},{"key":"10.1016\/j.yasu.2023.05.001_bib2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1186\/s12885-015-1632-z","volume":"15","author":"Smith","year":"2015","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.yasu.2023.05.001_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.yasu.2023.05.001_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","article-title":"Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial","volume":"16","author":"Garcia-Aguilar","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2023.05.001_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/DCR.0b013e3181fb7b82","article-title":"Sexual function after treatment for rectal cancer: a review","volume":"54","author":"Ho","year":"2011","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.yasu.2023.05.001_bib6","first-page":"106","article-title":"Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial","volume":"14","author":"Chen","year":"2015","journal-title":"Clin Colorectal Cancer"},{"issue":"17","key":"10.1016\/j.yasu.2023.05.001_bib7","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"31","key":"10.1016\/j.yasu.2023.05.001_bib8","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","article-title":"Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03","volume":"27","author":"Roh","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"16","key":"10.1016\/j.yasu.2023.05.001_bib9","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1002\/cncr.25943","article-title":"Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer","volume":"117","author":"Park","year":"2011","journal-title":"Cancer"},{"issue":"34","key":"10.1016\/j.yasu.2023.05.001_bib10","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","article-title":"Prognostic significance of tumor regression after\u00a0preoperative chemoradiotherapy for rectal cancer","volume":"23","author":"R\u00f6del","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.yasu.2023.05.001_bib11","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1200\/JCO.2013.54.3769","article-title":"Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO\/ARO\/AIO-94 trial","volume":"32","author":"Fokas","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"14","key":"10.1016\/j.yasu.2023.05.001_bib12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJM199704033361402","article-title":"Improved survival with preoperative radiotherapy in resectable rectal cancer","volume":"336","author":"Swedish Rectal Cancer Trial","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.yasu.2023.05.001_bib13","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"9666","key":"10.1016\/j.yasu.2023.05.001_bib14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"issue":"31","key":"10.1016\/j.yasu.2023.05.001_bib15","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"15_suppl","key":"10.1016\/j.yasu.2023.05.001_bib16","first-page":"3500","article-title":"Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine\u00a0+\/- oxaliplatin in locally advanced rectal cancer: Final results of PETACC-6","volume":"36","author":"Schmoll","year":"2018","journal-title":"J\u00a0Clin Orthod"},{"issue":"9","key":"10.1016\/j.yasu.2023.05.001_bib17","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1080\/0284186X.2019.1631473","article-title":"Five-year oncological outcomes after selective neoadjuvant radiotherapy for resectable rectal cancer","volume":"58","author":"Banwell","year":"2019","journal-title":"Acta Oncol"},{"issue":"13","key":"10.1016\/j.yasu.2023.05.001_bib18","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1245\/s10434-013-3198-9","article-title":"Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials","volume":"20","author":"Rahbari","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.yasu.2023.05.001_bib19","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/annonc\/mdv223","article-title":"Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial","volume":"26","author":"Fernandez-Martos","year":"2015","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.yasu.2023.05.001_bib20","doi-asserted-by":"crossref","first-page":"e180071","DOI":"10.1001\/jamaoncol.2018.0071","article-title":"Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer","volume":"4","author":"Cercek","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.yasu.2023.05.001_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.1683","article-title":"Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial","author":"Rahma","year":"2021","journal-title":"JAMA Oncol"},{"issue":"15","key":"10.1016\/j.yasu.2023.05.001_bib22","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1200\/JCO.2011.39.7901","article-title":"Neoadjuvant treatment response as an early response indicator for patients with rectal cancer","volume":"30","author":"Park","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.yasu.2023.05.001_bib23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ijrobp.2013.12.012","article-title":"Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control","volume":"88","author":"Habr-Gama","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.yasu.2023.05.001_bib24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00268-020-05795-6","article-title":"A\u00a0Snapshot of the International Views of the Treatment of Rectal Cancer Patients, a Multi-regional Survey: International Tendencies in Rectal Cancer","volume":"45","author":"Caycedo-Marulanda","year":"2021","journal-title":"World J Surg"},{"issue":"5","key":"10.1016\/j.yasu.2023.05.001_bib25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-0037-1606117","article-title":"Organ-Preserving Strategies for the Management of Near-Complete Responses in Rectal Cancer after Neoadjuvant Chemoradiation","volume":"30","author":"Lynn","year":"2017","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.yasu.2023.05.001_bib26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fonc.2019.00318","article-title":"Organ Preservation in Rectal Cancer: The Patients\u2019 Perspective","volume":"9","author":"Gani","year":"2019","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.yasu.2023.05.001_bib27","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/DCR.0000000000001166","article-title":"Patient and Physician Preferences for Nonoperative Management for Low Rectal Cancer: Is It a Reasonable Treatment Option?","volume":"61","author":"Kennedy","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"10.1016\/j.yasu.2023.05.001_bib28","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/bjs.9223","article-title":"Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer","volume":"100","author":"Emmertsen","year":"2013","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.yasu.2023.05.001_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/02841860701697720","article-title":"Preoperative staging of rectal cancer","volume":"47","author":"Smith","year":"2008","journal-title":"Acta Oncol"},{"key":"10.1016\/j.yasu.2023.05.001_bib30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.suronc.2020.08.013","article-title":"Lateral lymph node and its association with distant recurrence in rectal cancer: A clue of systemic disease","volume":"35","author":"Kim","year":"2020","journal-title":"Surg Oncol"},{"issue":"6","key":"10.1016\/j.yasu.2023.05.001_bib31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/DCR.0000000000001337","article-title":"Organ Preservation Among Patients With Clinically Node-Positive Rectal Cancer: Is It Really More Dangerous?","volume":"62","author":"Habr-Gama","year":"2019","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.yasu.2023.05.001_bib32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.amjsurg.2020.01.001","article-title":"Predictors for complete pathological response for stage II and III rectal cancer following neoadjuvant therapy - A systematic review and meta-analysis","volume":"220","author":"Huang","year":"2020","journal-title":"Am J Surg"},{"issue":"9","key":"10.1016\/j.yasu.2023.05.001_bib33","doi-asserted-by":"crossref","first-page":"e45388","DOI":"10.1371\/journal.pone.0045388","article-title":"P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.yasu.2023.05.001_bib34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/SLA.0b013e31822b8cfa","article-title":"Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer","volume":"254","author":"Garcia-Aguilar","year":"2011","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.yasu.2023.05.001_bib35","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/s41591-022-01930-z","article-title":"Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer","volume":"28","author":"Chatila","year":"2022","journal-title":"Nat Med"},{"issue":"25","key":"10.1016\/j.yasu.2023.05.001_bib36","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1200\/JCO.2016.66.6826","article-title":"DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics","volume":"34","author":"de Rosa","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"10139","key":"10.1016\/j.yasu.2023.05.001_bib37","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.yasu.2023.05.001_bib38","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.yasu.2023.05.001_bib39","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1245\/s10434-015-4687-9","article-title":"Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment","volume":"22","author":"Maas","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.yasu.2023.05.001_bib40","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/DCR.0b013e3181f42b89","article-title":"Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization","volume":"53","author":"Habr-Gama","year":"2010","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.yasu.2023.05.001_bib41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejrad.2017.08.009","article-title":"Value of DCE-MRI for staging and response evaluation in rectal cancer: A systematic review","volume":"95","author":"Dijkhoff","year":"2017","journal-title":"Eur J Radiol"},{"issue":"23","key":"10.1016\/j.yasu.2023.05.001_bib42","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1158\/1078-0432.CCR-17-1038","article-title":"Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer","volume":"23","author":"Liu","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.yasu.2023.05.001_bib43","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1080\/0284186X.2016.1235797","article-title":"Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy","volume":"55","author":"Hall","year":"2016","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2023.05.001_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2014.05.023","article-title":"Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost","volume":"90","author":"Appelt","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.yasu.2023.05.001_bib45","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ijrobp.2020.06.013","article-title":"Efficacy of Dose-Escalated Chemoradiation on Complete Tumor Response in Patients with Locally Advanced Rectal Cancer (RECTAL-BOOST): A Phase 2 Randomized Controlled Trial","volume":"108","author":"Couwenberg","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.yasu.2023.05.001_bib46","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1200\/JCO.2013.51.7904","article-title":"Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial","volume":"32","author":"Schrag","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.yasu.2023.05.001_bib47","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.yasu.2023.05.001_bib48","unstructured":"Alliance for Clinical Trials in Oncology. The Janus Rectal Cancer Trial: A Randomized Phase II Trial Testing The Efficacy of Triplet Versus Doublet Chemotherapy to Achieve Clinical Complete Response in Patients With Locally Advanced Rectal Cancer. clinicaltrials.gov; 2022. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05610163. Accessed November 29, 2022."},{"issue":"8","key":"10.1016\/j.yasu.2023.05.001_bib49","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/bjs.9811","article-title":"Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer","volume":"102","author":"Pettersson","year":"2015","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.yasu.2023.05.001_bib50","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jamcollsurg.2015.04.010","article-title":"Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation","volume":"221","author":"Probst","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"issue":"34","key":"10.1016\/j.yasu.2023.05.001_bib51","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1200\/JCO.19.00308","article-title":"Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO\/ARO\/AIO-12","volume":"37","author":"Fokas","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.yasu.2023.05.001_bib52","first-page":"e215445","article-title":"Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO\/ARO\/AIO-12 Randomized Clinical Trial","author":"Fokas","year":"2021","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2023.05.001_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.yasu.2023.05.001_bib54","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.yasu.2023.05.001_bib55","first-page":"e185","article-title":"Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial","volume":"20","author":"Kim","year":"2021","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.yasu.2023.05.001_bib56","unstructured":"R\u00f6del PD med C. Short-Course Radiotherapy Versus Chemoradiotherapy, Followed by Consolidation Chemotherapy, and Selective Organ Preservation for MRI-Defined Intermediate and High-Risk Rectal Cancer Patients. clinicaltrials.gov; 2021. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04246684. Accessed November 25, 2021."},{"issue":"7","key":"10.1016\/j.yasu.2023.05.001_bib57","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2468-1253(17)30074-2","article-title":"A\u00a0watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis","volume":"2","author":"Dossa","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.yasu.2023.05.001_bib58","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/bjs.8702","article-title":"Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer","volume":"99","author":"Martin","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.yasu.2023.05.001_bib59","doi-asserted-by":"crossref","first-page":"e185896","DOI":"10.1001\/jamaoncol.2018.5896","article-title":"Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy","author":"Smith","year":"2019","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.yasu.2023.05.001_bib60","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/DCR.0000000000002122","article-title":"Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy","volume":"64","author":"Jimenez-Rodriguez","year":"2021","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.yasu.2023.05.001_bib61","doi-asserted-by":"crossref","DOI":"10.1097\/DCR.0000000000002494","article-title":"The Risk of Distant Metastases in Patients With Clinical Complete Response Managed By Watch & Wait After Neoadjuvant Therapy For Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database","author":"Fernandez","year":"2023","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.yasu.2023.05.001_bib62","first-page":"znab372","article-title":"Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years","author":"Bahadoer","year":"2021","journal-title":"Br J Surg"},{"issue":"10","key":"10.1016\/j.yasu.2023.05.001_bib63","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/DCR.0000000000000862","article-title":"Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study","volume":"60","author":"Hupkens","year":"2017","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"10.1016\/j.yasu.2023.05.001_bib64","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/DCR.0000000000001646","article-title":"Patient-Reported Bowel Function in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy After Neoadjuvant Therapy: A Case-Control Study","volume":"63","author":"Quezada-Diaz","year":"2020","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.yasu.2023.05.001_bib65","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/SLA.0b013e3182759f1c","article-title":"Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy","volume":"256","author":"Smith","year":"2012","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.yasu.2023.05.001_bib66","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(15)00120-5","article-title":"High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study","volume":"16","author":"Appelt","year":"2015","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.yasu.2023.05.001_bib67","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00384-015-2460-y","article-title":"Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or \u201cwatch and wait","volume":"31","author":"Lai","year":"2016","journal-title":"Int J Colorectal Dis"},{"issue":"12","key":"10.1016\/j.yasu.2023.05.001_bib68","doi-asserted-by":"crossref","first-page":"djw171","DOI":"10.1093\/jnci\/djw171","article-title":"Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer","volume":"108","author":"Martens","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.yasu.2023.05.001_bib69","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(15)00467-2","article-title":"Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis","volume":"17","author":"Renehan","year":"2016","journal-title":"Lancet Oncol"},{"issue":"10139","key":"10.1016\/j.yasu.2023.05.001_bib70","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"}],"container-title":["Advances in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065341123000155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065341123000155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T20:31:43Z","timestamp":1758745903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065341123000155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0065341123000155"],"URL":"https:\/\/doi.org\/10.1016\/j.yasu.2023.05.001","relation":{},"ISSN":["0065-3411"],"issn-type":[{"type":"print","value":"0065-3411"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Nonoperative Management of Rectal Cancer Feasible?","name":"articletitle","label":"Article Title"},{"value":"Advances in Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yasu.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}